CS2009 data interpretation
Search documents
CStone Pharmaceuticals (CSPHF) Discusses CS2009 Data Interpretation and Future Clinical Development Strategy Transcript
Seeking Alpha· 2025-10-21 10:44
PresentationZiyi ChenGoldman Sachs Group, Inc., Research Division Great. Good morning, global investors. Thank you for joining CStone Pharmaceuticals' ESMO Data Review Conference Call. The call is going to be mainly focused on the CF2009 data readouts at the recent medical conference, ESMO. So today, joined our call, including Jason Yang, CEO of the company; and also Nicky Ni, CFO of the company. This is Ziyi Chen, China health care analyst at Goldman Sachs. I'm going to be moderating the call. Before we ki ...